Apexigen, Inc.
Apexigen, Inc., a leading biotechnology firm headquartered in the United States, is at the forefront of immuno-oncology innovation. Founded in 2015, the company has rapidly established itself in the biopharmaceutical industry, focusing on the development of novel antibody therapeutics designed to enhance the body’s immune response against cancer. With a strong emphasis on its proprietary APX005M product, Apexigen aims to provide unique solutions that address unmet medical needs in oncology. The company’s commitment to advancing cancer treatment has garnered recognition within the industry, positioning it as a notable player in the competitive landscape of cancer therapeutics. Apexigen continues to expand its operational reach, striving to make significant contributions to patient care and treatment outcomes globally.
DitchCarbon Score
How does Apexigen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apexigen, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Apexigen, Inc.'s reported carbon emissions
Apexigen, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, Apexigen may inherit climate commitments and emissions data from its parent organisation; however, no specific details have been provided regarding such cascaded information. The lack of reported emissions and reduction initiatives suggests that Apexigen is still in the early stages of developing its climate strategy or may rely on broader corporate family commitments for guidance. In the context of the industry, it is essential for companies like Apexigen to establish clear climate commitments and reduction targets to align with global sustainability goals and enhance their environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Apexigen, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
